RedHill Biopharma Ltd.: The Strategic Expansion and Clinical Progress are in line with the Company’s plans. Stock Target Price Unchanged.

• Post author:jaimeuss_admin
• Post published:6 בSeptember 2018
• Post category:Research
• Post comments:0 Comments

Continue ReadingRedHill Biopharma Ltd.: The Strategic Expansion and Clinical Progress are in line with the Company’s plans. Stock Target Price Unchanged.

Energix Renewable Energies Ltd.: The revenues in H1 2017 attest the implementation of plans and expected growth in cash flows from projects. Target Price Unchanged.

• Post author:jaimeuss_admin
• Post published:6 בSeptember 2018
• Post category:Research
• Post comments:0 Comments

Continue ReadingEnergix Renewable Energies Ltd.: The revenues in H1 2017 attest the implementation of plans and expected growth in cash flows from projects. Target Price Unchanged.

Cellect Biotechnology Ltd.: Company’s clinical development on track; we expect positive interim results in the coming months. Target Price unchanged.

• Post author:jaimeuss_admin
• Post published:30 בAugust 2018
• Post category:Research
• Post comments:0 Comments

Continue ReadingCellect Biotechnology Ltd.: Company’s clinical development on track; we expect positive interim results in the coming months. Target Price unchanged.

Brainsway Ltd.: Market Trends Drive Revenue Growth. An Opportunity for Increased Value based on the scenario of the Successful Execution of the New Business Model

• Post author:jaimeuss_admin
• Post published:30 בAugust 2018
• Post category:Research
• Post comments:0 Comments

Continue ReadingBrainsway Ltd.: Market Trends Drive Revenue Growth. An Opportunity for Increased Value based on the scenario of the Successful Execution of the New Business Model